Novartis Oncology Global Website - Online Resources: Cancer Causes, Treatments & Strategies

Home

Products


learn more ›	learn more ›	learn more ›	learn more ›	learn more ›	learn more ›

LATEST NEWS

June 13, 2008

Higher initial dose of Glivec achieved better early responses than standard dose for patients with chronic myeloid leukemia

June 02, 2008

Early data presented at ASCO show potential of RAD001 to enhance efficacy of, and overcome resistance to, breast cancer treatments

Visit our newsroom

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.